Medicare tightens hospice oversight to combat fraud; smaller providers face compliance costs.

What it does

This bill increases federal oversight of Medicare hospice programs and home health agencies by requiring more frequent inspections of newly enrolled or high-risk providers, mandating quality data submission with financial penalties for non-compliance, and strengthening enrollment screening to detect fraud. It also requires Medicare to send beneficiaries written notice when they elect hospice care, and directs CMS to report annually on fraud-detection activities. The bill allocates $106 million to fund these oversight activities.

Why we flagged it

The bill's operative mechanism is regulatory tightening—increased survey frequency, quality data mandates, enrollment screening, and accreditation standards—all aimed at detecting and preventing fraud in hospice and home health programs. This is a straightforward public-integrity measure, not a subsidy, carve-out, or deregulation.

What the text implies

• Payment penalties for non-submission of quality data rise from 4 percentage points (2024–2028) to 15 percentage points (2029+) for hospice, and 2 to 15 percentage points for home health—a significant financial pressure that may force smaller or struggling providers to exit the market or consolidate.
• The 'extreme risk of fraud' determination is delegated to CMS with minimal statutory definition, giving the agency broad discretion to impose fingerprinting and insurance requirements on providers in high-risk areas—potentially creating barriers to entry for new providers in underserved regions.
• Accreditation organizations must now meet state-survey standards and require CMS-approved surveyor training; CMS may retroactively revoke prior approvals if standards are not met within one year—creating retroactive compliance risk for accreditors and potential service disruption.
• The bill extends the hospice cap-amount adjustment through 2036 (previously 2025), locking in a payment methodology change that may reduce hospice provider revenue but is framed as a technical extension rather than a policy choice.
• Annual reporting on program integrity activities may create public pressure for enforcement actions and revocations, potentially incentivizing CMS to pursue cases aggressively to demonstrate activity, even where evidence is marginal.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary Medicare beneficiaries gain stronger protections against fraud and abuse in hospice and home health services—sectors with documented integrity problems—through increased inspections, quality reporting requirements, and better enrollment screening. The written notice requirement ensures beneficiaries understand their hospice election. The primary cost is administrative burden on providers, which is justified by the public interest in preventing improper payments and protecting vulnerable

Who stands to gain

• Medicare Trust Fund (reduced improper payments)
• CMS contractors and auditors (increased survey and compliance work)
• Accreditation organizations meeting new standards (competitive advantage over non-compliant bodies)

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS), Federal Hospital Insurance Trust Fund, Hospice programs (Medicare-enrolled), Home health agencies (Medicare-enrolled), National accreditation bodies, State and local survey agencies

Where it stands

• May 19, 2026 — Introduced · Congress.gov: “Introduced in House”
• May 19, 2026 — Referred to House Committee on Energy and Commerce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a…”
• May 21, 2026 — Markup held in committee · Congress.gov: “Committee Consideration and Mark-up Session Held”
• May 21, 2026 — Reported out of committee · Congress.gov: “Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 27 - 16”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

9 lobbying clients named this bill on 9 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $1,175,000 in lobbying spend. A filing names 10 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 89% of bills with at least one filing.

Beth Van Duyne, the sponsor, reported $1,221,522 in PAC receipts in the 2026 cycle.

• National Alliance for Care at Home (formerly Natl Assn for Home Care & Hospice) — $610,000 on 1 filing
• Vitas Healthcare Corporation — $230,000 on 1 filing
• Addus Homecare — $60,000 on 1 filing
• National Alliance for Care at Home — $60,000 on 1 filing
• Bayada Hearts for Homecare — $50,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.